Furthermore, the reduced level of HIF reduces the expression of the GLUT-1 transporter and consequently decreases glucose uptake into tumour cells, lactate production, Akt and mTOR signalling, and cell viability, depending on the dose and time. The gene discussed is MTOR; the disease is neoplasm.